Elicio Therapeutics, Inc. (ELTX)

NASDAQ: ELTX · IEX Real-Time Price · USD
7.60
+0.14 (1.88%)
At close: Mar 28, 2024, 4:00 PM
7.41
-0.19 (-2.50%)
After-hours: Mar 28, 2024, 5:48 PM EDT

Total Valuation

ELTX has a market cap or net worth of $72.57 million. The enterprise value is $63.21 million.

Market Cap 72.57M
Enterprise Value 63.21M

Important Dates

The next estimated earnings date is Wednesday, May 15, 2024, before market open.

Earnings Date May 15, 2024
Ex-Dividend Date n/a

Share Statistics

ELTX has 10.22 million shares outstanding. The number of shares has increased by 2,538.13% in one year.

Shares Outstanding 10.22M
Shares Change (YoY) +2,538.13%
Shares Change (QoQ) +170.12%
Owned by Insiders (%) 55.49%
Owned by Institutions (%) 6.43%
Float 3.64M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 5.46
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.54.

Current Ratio 1.74
Quick Ratio n/a
Debt / Equity 0.54
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -92.27

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -87.80%
Return on Capital (ROIC) -147.79%
Revenue Per Employee n/a
Profits Per Employee -$1.27M
Employee Count 23
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +45.02% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change +45.02%
50-Day Moving Average 4.74
200-Day Moving Average 7.36
Relative Strength Index (RSI) 78.36
Average Volume (30 Days) 119,386

Short Selling Information

The latest short interest is 28,405, so 0.28% of the outstanding shares have been sold short.

Short Interest 28,405
Short Previous Month 23,536
Short % of Shares Out 0.28%
Short % of Float 0.78%
Short Ratio (days to cover) 0.54

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -30.21M
Pretax Income -29.19M
Net Income -29.19M
EBITDA -27.76M
EBIT -28.88M
Earnings Per Share (EPS) -$7.31
Full Income Statement

Balance Sheet

The company has $16.51 million in cash and $7.15 million in debt, giving a net cash position of $9.36 million or $0.92 per share.

Cash & Cash Equivalents 16.51M
Total Debt 7.15M
Net Cash 9.36M
Net Cash Per Share $0.92
Equity / Book Value 13.29M
Book Value Per Share 1.30
Working Capital 8.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.22 million and capital expenditures -$32,000, giving a free cash flow of -$27.26 million.

Operating Cash Flow -27.22M
Capital Expenditures -32,000
Free Cash Flow -27.26M
FCF Per Share -$3.25
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ELTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2,538.13%
Shareholder Yield -2,538.13%
Earnings Yield -40.23%
FCF Yield -37.56%

Analyst Forecast

The average price target for ELTX is $11.00, which is 44.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target $11.00
Price Target Difference 44.74%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 60.58%
EPS Growth Forecast (5Y) -36.55%
Stock Forecasts

Stock Splits

The last stock split was on June 2, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date Jun 2, 2023
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 1